Related Experiment Video
Updated: Jun 17, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
[Erythropoietin and radiotherapy]
E Le Fur1, M-N Albarghach, O Pradier
1Département de radiothérapie, CHU de Morvan, Brest, France.
Summary
Erythropoietin (EPO) can increase red blood cell production, improving anemia and quality of life. However, its use with radiotherapy is debated due to potential risks of tumor progression and new blood vessel growth.
Area of Science:
- Hematology
- Oncology
- Endocrinology
Context:
- Erythropoietin (EPO) is a glycoprotein hormone crucial for red blood cell production.
- EPO stimulates erythroblast proliferation in bone marrow via specific receptors.
- Clinical studies confirm EPO's efficacy in increasing hemoglobin and improving patient quality of life.
Purpose:
- To evaluate the controversial role of Erythropoietin (EPO) in cancer patients undergoing radiotherapy.
- To determine if EPO has a place in combination cancer treatment protocols involving radiotherapy.
Summary:
- Tumor hypoxia, often caused by anemia, contributes to radioresistance and local treatment failure.
- Conversely, tumor cells expressing EPO receptors may experience increased progression and neo-angiogenesis with EPO administration.
- This presents a significant risk, complicating the potential benefits of EPO in radiotherapy settings.
Impact:
- Clarifies the complex risk-benefit profile of using Erythropoietin (EPO) alongside radiotherapy.
- Provides critical insights for oncologists regarding EPO's potential role in managing cancer patients treated with radiation.
- Highlights the need for careful patient selection and consideration of tumor biology when contemplating EPO therapy in conjunction with radiotherapy.
Related Concept Videos
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...